Clinical trial
Sirolimus-Coated Balloon (SeQuent SCB) Versus Paclitaxel-Coated Balloon (RESTORE DEB) for Recurrent Coronary In-Stent Restenosis Following Prior Paclitaxel-Coated Balloon Therapy: A Multicenter, Randomized, Open-Label, Noninferiority Trial
NCT07920055 is registered in ClinicalTrials.gov with Sir Run Run Shaw Hospital as lead sponsor.
Follow this trial by email Email me the PDF
Summary
Not yet recruiting, started November 2026. Interventional study, 106 participants (estimated). Lead sponsor Sir Run Run Shaw Hospital; China. Primary measure: In-Segment Late Lumen Loss at 9 Months.
How it compares
1,721 similar trials: same condition (Coronary Artery Disease) and phase
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sirolimus-Coated Balloon (SeQuent SCB) Versus Paclitaxel-Coated Balloon (RESTORE DEB) for Recurrent Coronary In-Stent Restenosis Following Prior Paclitaxel-Coated Balloon Therapy: A Multicenter, Randomized, Open-Label, Noninferiority Trial
- Lead sponsor
- Sir Run Run Shaw Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 1, 2026
- Completion date
- November 30, 2028
- Enrollment
- 106 (estimated)
- Sites
- 1
Conditions
MeSH condition names; the registry's own terms follow.
Registry terms: coronary in-stent restenosis
Who could take part, where it ran, who ran it
As filed in ClinicalTrials.gov.
- Sex
- All
- Minimum age
- 18 Years
- Healthy volunteers
- No
- Study type
- Interventional
- Sites
- 1
- Countries
- China
- Lead sponsor
- Sir Run Run Shaw Hospital
Arms
As registered; 2 arms.
| Arm | Type | Interventions |
|---|---|---|
| SeQuent SCB Sirolimus-Coated Balloon | Experimental | SeQuent SCB sirolimus-coated balloon |
Show registry wordingTreatment of eligible recurrent coronary in-stent restenosis with SeQuent SCB sirolimus-coated balloon angioplasty. Up to two balloons may be used per participant under the protocol. All participants receive protocol-directed antiplatelet treatment | ||
| RESTORE DEB Paclitaxel-Coated Balloon | Active comparator | RESTORE DEB paclitaxel-coated balloon |
Show registry wordingTreatment of eligible recurrent coronary in-stent restenosis with RESTORE DEB paclitaxel-coated balloon angioplasty. Up to two balloons may be used per participant under the protocol. All participants receive protocol-directed antiplatelet treatment | ||
Primary endpoints
Registered primary outcome measures; 1 primary.
| Measure | Time frame |
|---|---|
| In-Segment Late Lumen Loss at 9 Months | Immediately after index procedure and at 9 months |
Show registry wordingDifference, in millimeters, between the in-segment minimum lumen diameter immediately after balloon angioplasty and the minimum lumen diameter in the same segment at 9 months, measured by blinded quantitative coronary angiography. The prespecified noninferiority margin for the adjusted mean difference (SeQuent SCB minus RESTORE DEB) is 0.25 mm. | |
Lead sponsor's other trials
Sir Run Run Shaw Hospital, most recent start first.
+129 more trials See the organization page
Similar trials
Same condition (Coronary Artery Disease) and phase, most recent start first.
+1,716 more trials See the condition page